vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Liberty Energy Inc. (LBRT). Click either name above to swap in a different company.
Liberty Energy Inc. is the larger business by last-quarter revenue ($1.0B vs $950.5M, roughly 1.1× Astrana Health, Inc.). Liberty Energy Inc. runs the higher net margin — 2.2% vs 0.7%, a 1.5% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 4.5%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs -6.2%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Liberty Energy Inc. is a North American energy services provider specializing in hydraulic fracturing and well completion solutions for oil and gas operators. It serves clients across major U.S. shale basins, offering low-emission equipment and tailored support to optimize well productivity.
ASTH vs LBRT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.0B |
| Net Profit | $6.6M | $22.6M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | 2.2% |
| Net Margin | 0.7% | 2.2% |
| Revenue YoY | 42.9% | 4.5% |
| Net Profit YoY | 184.4% | 64.8% |
| EPS (diluted) | $0.12 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.0B | ||
| Q4 25 | $950.5M | $1.0B | ||
| Q3 25 | $956.0M | $947.4M | ||
| Q2 25 | $654.8M | $1.0B | ||
| Q1 25 | $620.4M | $977.5M | ||
| Q4 24 | $665.2M | $943.6M | ||
| Q3 24 | $478.7M | $1.1B | ||
| Q2 24 | $486.3M | $1.2B |
| Q1 26 | — | $22.6M | ||
| Q4 25 | $6.6M | $13.7M | ||
| Q3 25 | $373.0K | $43.1M | ||
| Q2 25 | $9.4M | $71.0M | ||
| Q1 25 | $6.7M | $20.1M | ||
| Q4 24 | $-7.8M | $51.9M | ||
| Q3 24 | $16.1M | $73.8M | ||
| Q2 24 | $19.2M | $108.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 20.6% | ||
| Q3 25 | — | 18.7% | ||
| Q2 25 | — | 22.1% | ||
| Q1 25 | — | 22.1% | ||
| Q4 24 | — | 21.4% | ||
| Q3 24 | — | 26.2% | ||
| Q2 24 | — | 27.9% |
| Q1 26 | — | 2.2% | ||
| Q4 25 | 1.9% | 1.9% | ||
| Q3 25 | 2.0% | -0.3% | ||
| Q2 25 | 3.1% | 3.6% | ||
| Q1 25 | 3.3% | 1.9% | ||
| Q4 24 | 0.1% | 2.6% | ||
| Q3 24 | 5.9% | 9.4% | ||
| Q2 24 | 6.2% | 12.2% |
| Q1 26 | — | 2.2% | ||
| Q4 25 | 0.7% | 1.3% | ||
| Q3 25 | 0.0% | 4.5% | ||
| Q2 25 | 1.4% | 6.8% | ||
| Q1 25 | 1.1% | 2.1% | ||
| Q4 24 | -1.2% | 5.5% | ||
| Q3 24 | 3.4% | 6.5% | ||
| Q2 24 | 3.9% | 9.3% |
| Q1 26 | — | $0.14 | ||
| Q4 25 | $0.12 | $0.08 | ||
| Q3 25 | $0.01 | $0.26 | ||
| Q2 25 | $0.19 | $0.43 | ||
| Q1 25 | $0.14 | $0.12 | ||
| Q4 24 | $-0.14 | $0.31 | ||
| Q3 24 | $0.33 | $0.44 | ||
| Q2 24 | $0.40 | $0.64 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $699.1M |
| Total DebtLower is stronger | — | $7.1M |
| Stockholders' EquityBook value | $779.3M | $1.9B |
| Total Assets | $2.2B | $4.4B |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $699.1M | ||
| Q4 25 | $429.5M | $27.6M | ||
| Q3 25 | $463.4M | $13.5M | ||
| Q2 25 | $342.1M | $19.6M | ||
| Q1 25 | $260.9M | $24.1M | ||
| Q4 24 | $290.8M | $20.0M | ||
| Q3 24 | $350.3M | $23.0M | ||
| Q2 24 | $327.7M | $30.0M |
| Q1 26 | — | $7.1M | ||
| Q4 25 | — | $246.6M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $190.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $1.9B | ||
| Q4 25 | $779.3M | $2.1B | ||
| Q3 25 | $775.5M | $2.1B | ||
| Q2 25 | $765.5M | $2.0B | ||
| Q1 25 | $745.4M | $2.0B | ||
| Q4 24 | $712.7M | $2.0B | ||
| Q3 24 | $704.6M | $2.0B | ||
| Q2 24 | $678.9M | $1.9B |
| Q1 26 | — | $4.4B | ||
| Q4 25 | $2.2B | $3.6B | ||
| Q3 25 | $2.2B | $3.5B | ||
| Q2 25 | $1.4B | $3.4B | ||
| Q1 25 | $1.3B | $3.4B | ||
| Q4 24 | $1.4B | $3.3B | ||
| Q3 24 | $1.3B | $3.3B | ||
| Q2 24 | $1.3B | $3.2B |
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.10× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | — |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | 13.1% |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $195.4M | ||
| Q3 25 | $10.0M | $51.5M | ||
| Q2 25 | $90.9M | $170.6M | ||
| Q1 25 | $16.6M | $192.1M | ||
| Q4 24 | $-10.9M | $177.3M | ||
| Q3 24 | $34.0M | $244.5M | ||
| Q2 24 | $23.2M | $248.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $-10.0M | ||
| Q3 25 | $7.4M | $-67.2M | ||
| Q2 25 | $89.5M | $33.1M | ||
| Q1 25 | $13.6M | $58.2M | ||
| Q4 24 | $-13.5M | $-26.2M | ||
| Q3 24 | $31.7M | $77.9M | ||
| Q2 24 | $20.4M | $112.2M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | -1.0% | ||
| Q3 25 | 0.8% | -7.1% | ||
| Q2 25 | 13.7% | 3.2% | ||
| Q1 25 | 2.2% | 6.0% | ||
| Q4 24 | -2.0% | -2.8% | ||
| Q3 24 | 6.6% | 6.8% | ||
| Q2 24 | 4.2% | 9.7% |
| Q1 26 | — | 13.1% | ||
| Q4 25 | 0.3% | 19.8% | ||
| Q3 25 | 0.3% | 12.5% | ||
| Q2 25 | 0.2% | 13.2% | ||
| Q1 25 | 0.5% | 13.7% | ||
| Q4 24 | 0.4% | 21.6% | ||
| Q3 24 | 0.5% | 14.6% | ||
| Q2 24 | 0.6% | 11.7% |
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 14.28× | ||
| Q3 25 | 26.69× | 1.20× | ||
| Q2 25 | 9.65× | 2.40× | ||
| Q1 25 | 2.48× | 9.55× | ||
| Q4 24 | — | 3.42× | ||
| Q3 24 | 2.11× | 3.31× | ||
| Q2 24 | 1.21× | 2.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
LBRT
Segment breakdown not available.
